Kienle, Dirk L.; Dietrich, Daniel; Ribi, Karin; Wicki, Andreas; Quagliata, Luca; Winterhalder, Ralph C.; Koeberle, Dieter; Horber, Daniel; Bastian, Sara; Kueng, Marc; Saletti, Piercarlo; Helbling, Daniel; Baertschi, Daniela; Lugli, Alessandro; Bernhard, Jürg; Andrieu, Christiane; von Moos, Roger (2019). Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. Journal of geriatric oncology, 10(2), pp. 304-310. Elsevier 10.1016/j.jgo.2018.11.011
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Kienle SAKK 41-10.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (358kB) | Request a copy |
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology 04 Faculty of Medicine > Service Sector > Institute of Pathology 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Lugli, Alessandro, Bernhard, Jürg Theodor |
Subjects: |
500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine & health |
ISSN: |
1879-4068 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
14 Feb 2019 08:56 |
Last Modified: |
02 Mar 2023 23:31 |
Publisher DOI: |
10.1016/j.jgo.2018.11.011 |
PubMed ID: |
30559073 |
BORIS DOI: |
10.7892/boris.124918 |
URI: |
https://boris.unibe.ch/id/eprint/124918 |
Actions (login required)
 |
Edit item |